BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6295033)

  • 1. [Isolation of a purified theta-hemolysin from C1. perfingens type A and its use for titrating toxins and sera].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):40-3. PubMed ID: 6295033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective properties of theta-hemolysin obtained by affinity chromatography].
    Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theta-toxin of Clostridium perfringens. I. Purification and some properties.
    Yamakawa Y; Ito A; Sato H
    Biochim Biophys Acta; 1977 Oct; 494(2):301-13. PubMed ID: 199270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of Clostridium perfringens delta-toxin.
    Alouf JE; Jolivet-Reynaud C
    Infect Immun; 1981 Feb; 31(2):536-46. PubMed ID: 6260669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation of the theta-hemolysin of Cl. perfringens].
    Dolgikh MS; Blagoveshchenskiĭ VA; Sergeeva TI; Novoselova GN
    Vopr Med Khim; 1981; 27(1):129-32. PubMed ID: 6258318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and properties of theta-toxin of Clostridium perfringens with special reference to lethal activity.
    Soda S; Ito A; Yamamoto A
    Jpn J Med Sci Biol; 1976 Dec; 29(6):335-49. PubMed ID: 192930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Purification of Clostridium perfringens type A toxins by DEAE-ion exchanger and gel filtration].
    Katsaras K; Hartwigk H
    Zentralbl Veterinarmed B; 1979 Oct; 26(8):623-34. PubMed ID: 230665
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of Clostridium perfringens type C theta toxin.
    Hauschild AH; Lecroisey A; Alouf JE
    Can J Microbiol; 1973 Aug; 19(8):881-5. PubMed ID: 4356555
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes.
    Stevens DL; Mitten J; Henry C
    J Infect Dis; 1987 Aug; 156(2):324-33. PubMed ID: 2885383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Production, purification and characterization of some Clostridium perfringens toxins].
    Capunzo M; Mariano A; Cavallo R
    G Batteriol Virol Immunol; 1982; 75(1-6):48-61. PubMed ID: 6315516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of beta-toxin from Clostridium perfringens type C.
    Sakurai J; Duncan CL
    Infect Immun; 1977 Dec; 18(3):741-5. PubMed ID: 201565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of salmolysin, an extracellular hemolytic toxin from Aeromonas salmonicida.
    Nomura S; Fujino M; Yamakawa M; Kawahara E
    J Bacteriol; 1988 Aug; 170(8):3694-702. PubMed ID: 3136147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.
    Haque A; Sugimoto N; Horiguchi Y; Okabe T; Miyata T; Iwanaga S; Matsuda M
    Infect Immun; 1992 Jan; 60(1):71-8. PubMed ID: 1729198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of Clostridium perfringens beta toxin.
    Sakurai J; Fujii Y
    Toxicon; 1987; 25(12):1301-10. PubMed ID: 2449745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification and purification of multiple forms of theta-haemolysin (theta-toxin) of Clostridium perfringens type A.
    Smyth CJ
    J Gen Microbiol; 1975 Apr; 87(2):219-38. PubMed ID: 167102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens.
    Stevens DL; Troyer BE; Merrick DT; Mitten JE; Olson RD
    J Infect Dis; 1988 Feb; 157(2):272-9. PubMed ID: 2891775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold-labile hemolysin produced by limited proteolysis of theta-toxin from Clostridium perfringens.
    Ohno-Iwashita Y; Iwamoto M; Mitsui K; Kawasaki H; Ando S
    Biochemistry; 1986 Oct; 25(20):6048-53. PubMed ID: 2878682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.